Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure
- 1 January 2002
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 42 (1) , 43-51
- https://doi.org/10.1177/0091270002042001005
Abstract
Levosimendan is a new calcium sensitizer developed for the short‐term intravenous treatment of congestive heart failure. The aims of the present open‐label, nonrandomized study were to determine the ...Keywords
This publication has 22 references indexed in Scilit:
- Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failureJournal of the American College of Cardiology, 2000
- Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart FailureCirculation, 2000
- Comparison of the Vasorelaxing Effect of Cromakalim and the New Inodilator, Levosimendan, in Human Isolated Portal VeinJournal of Pharmacy and Pharmacology, 2000
- Dose-ranging and safety with intravenous levosimendan in low-output heart failure: experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trialThe American Journal of Cardiology, 1999
- Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytesEuropean Journal of Pharmacology, 1997
- The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendanCardiovascular Research, 1997
- Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendanJournal of Molecular and Cellular Cardiology, 1995
- Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constrictionBritish Journal of Pharmacology, 1995
- Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1995
- Levosimendan (OR-1259), a Myofilament Calcium Sensitizer, Enhances Myocardial Contractility but Does Not Alter Isovolumic Relaxation in Conscious and Anesthetized DogsAnesthesiology, 1994